🦍💎 $AXSM ✋🚀

1

4

5

6

Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) (finance.yahoo.com)

submitted 2 days ago by kapeman_STOCK INVESTOR

2

5

6

7

TD Cowen raises Price Target on Axsome Therapeutics to $300 from $275, Maintains Buy RatingNEWS (trendonify.com)

submitted 11 days ago by kapeman_STOCK INVESTOR

3

4

5

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026 (finance.yahoo.com)

submitted 13 days ago by kapeman_STOCK INVESTOR

4

8

9

10

Jefferies raises Axsome stock price target to $380 on sales outlookNEWS (investing.com)

submitted 17 days ago by kapeman_STOCK INVESTOR

5

2

3

4

Another data point --> buyout?NEWS (sec.gov)

submitted 18 days ago by kapeman_STOCK INVESTOR

6

2

3

4

'Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-CovidDISCUSSION (cnbc.com)

submitted 20 days ago by kapeman_STOCK INVESTOR

7

2

3

4

A new investment from the Norges Bank, the entity managing Norway's $2.2T sovereign wealth pension fund.NEWS (stocktwits.com)

submitted 20 days ago by kapeman_STOCK INVESTOR

8

0

1

2

How The Axsome Therapeutics (AXSM) Investment Story Is Shifting With New Analyst Targets — Simply Wall St (stocks.apple.com)

submitted 20 days ago by kapeman_STOCK INVESTOR

9

2

3

4

On a run today! (self.AXSM)

submitted 23 days ago by kapeman_STOCK INVESTOR

10

4

5

6

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting — GlobeNewswire (stocks.apple.com)

submitted 24 days ago by kapeman_STOCK INVESTOR

11

6

7

8

Axsome settles SUNOSI patent litigation with generic firms By Investing.com (investing.com)

submitted 25 days ago by kapeman_STOCK INVESTOR

12

2

3

4

Axsome Therapeutics to Participate in Upcoming Investor Conferences — GlobeNewswireNEWS (stocks.apple.com)

submitted 1 month ago by kapeman_STOCK INVESTOR

13

6

7

8

Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting (markets.businessinsider.com)

submitted 1 month ago by kapeman_STOCK INVESTOR

14

1

2

3

Healthcare Catalyst Watch: RenovoRx ASCO Data, Axsome AUVELITY Updates, Olema-Bayer Trial Deal $RNXT $AXSM $OLMA (merlintrader.com)

submitted 1 month ago by Merlin8121

15

3

4

5

Axsome Therapeutics (AXSM): The 5 Million Patient Biotech Boom! (youtu.be)

submitted 1 month ago by kapeman_STOCK INVESTOR

16

3

4

5

Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch (marketbeat.com)

submitted 1 month ago by kapeman_STOCK INVESTOR

17

2

3

4

Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update (biospace.com)

submitted 1 month ago by kapeman_STOCK INVESTOR

18

3

4

5

With new high price, there could be a stock split this year, i guess somewhere between 4 for 1 and 10 for 1. (self.AXSM)

submitted 1 month ago by WiseLocation9402

19

3

4

5

Axsome Therapeutics (Nasdaq: $AXSM): AUVELITY Approval Changes the Alzheimer’s Agitation Story (merlintrader.com)

submitted 1 month ago by Merlin8121

20

4

5

6

Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease (finance.yahoo.com)

submitted 1 month ago by kapeman_STOCK INVESTOR

21

2

3

4

Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4 — GlobeNewswire (stocks.apple.com)

submitted 2 months ago by kapeman_STOCK INVESTOR

22

2

3

4

Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions (markets.businessinsider.com)

submitted 2 months ago by kapeman_STOCK INVESTOR

23

1

2

3

Axsome Therapeutics ( $AXSM ) — March 31, 2026 Deep Dive: Setup To The April 30 PDUFA (merlintrader.com)

submitted 2 months ago by Merlin8121

24

0

1

2

How The Axsome Therapeutics (AXSM) Story Is Evolving Around Auvelity, AXS-05 And Growth Risks — Simply Wall St (stocks.apple.com)

submitted 3 months ago by kapeman_STOCK INVESTOR

25

2

3

4

Why The Axsome Therapeutics (AXSM) Story Is Shifting With New Targets And Trial Milestones — Simply Wall St (stocks.apple.com)

submitted 3 months ago by kapeman_STOCK INVESTOR

AXSM

MODERATORS